Keywords: Mild; Moderate; Asthma; Lebrikizumab; AE; adverse event; AQLQ(S); Standardised Asthma Quality of Life Questionnaire; ATA; anti-therapeutic antibodies; FeNO; fractional exhaled nitric oxide; FEV1; forced expiratory volume in 1â¯s; HLGT; high level group t
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Adult asthma; Airway hyperresponsiveness; Asthma management; ICS; Step-down; Innate immunity; Regulatory T cell; IL-10; IL-33; ACh; Acetylcholine dichloride; Feno; Fractional exhaled nitric oxide; GINA; Global Initiative for Asthma; Hist; Histamine dihydr
Keywords: Adverse drug events; Effectiveness; Exacerbations; Omalizumab; Severe asthma; ADRs; adverse drug reaction; AEs; adverse events; GETE; global evaluation of treatment effectiveness; GINA; Global Initiative for Asthma; HCRU; health care resource utilization;
Keywords: Asthma control; Children; Asthma; Health resource utilization; Expenditures; AC; All-cause; ACQ; Asthma Control Questionnaire; AS; Asthma-specific; ED; Emergency department; HC; Household Component; HRU; Health resource utilization; ICD-9; International C
Keywords: Asthma; overweight; obesity; children; infants; exacerbation; AD; Asthma symptom days; BMI; Body mass index; ED; Emergency department; ICS; Inhaled corticosteroids; INFANT; Individualized Therapy for Asthma in Toddlers; LTRA; Leukotriene receptor antagoni
Keywords: COPD; chronic obstructive pulmonary disease; CVD; cardiovascular disease; DRS; disease risk score; ED; emergency department; ICD-9; International Classification of Diseases, Ninth Edition; ICS; inhaled corticosteroid; LABA; long-acting β2 agonist; LAMA;
Keywords: Asthma; Older adults; Elderly; Health care utilization; Environment; Cockroach; Mold; Cost; Chronic obstructive pulmonary disease; Depression; ACBS; Asthma Call-back Survey; BMI; Body mass index; BRFSS; Behavioral Risk Factor Surveillance System; CAD; Cor
Keywords: Asthma; Asthma knowledge; Asthma first-aid; Assessment; Questionnaire; SABA; Short acting beta agonist; AFA; Asthma first aid; AFAKQ; Asthma first aid knowledge questionnaire; AAP; Asthma action plan;
Keywords: asthma; critical care; pregnancy; primary medicine; ACQ; Asthma Control Questionnaire; ACT; Asthma Control Test; ECCO2R; extracorporeal carbon dioxide removal; ECMO; extracorporeal membrane oxygenation; ICS; inhaled corticosteroid; IT; immunotherapy; LABA
Keywords: Chinese herbal medicine formula; Acute asthma; Randomized controlled trial; Inflammatory cytokines; Proof-of-concept; ASHMI; antiasthma simplified herbal medicine intervention; CRP; C-reactive protein; ELISA; enzyme - linked immunosorbent assay; ERS; Euro
Keywords: The trial was registered under NCT02433834 at; http://www.clinicaltrials.gov; Asthma; Co-suspension delivery technology; Glycopyrronium; Inhaled corticosteroid use; Metered dose inhaler; ACQ-5; Asthma Control Questionnaire-5; AE; adverse event; AUC0-3;
Keywords: Pediatric; Summer camp; Allergy; Anaphylaxis; Asthma; Epinephrine autoinjector; Urgent care; Emergency care; EHR; Electronic health record; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; NHANES; National Health and Nutrition Examination Survey
Metabolomic profiling of doxycycline treatment in chronic obstructive pulmonary disease
Keywords: COPD; chronic obstructive pulmonary disease; WHO; World health organization; FEV1; forced expiratory volume in 1Â s; FVC; forced vital capacity; CAT; COPD Assessment Test; SGRQ; St George's respiratory questionnaire; MMP; matrix metalloproteases; NMR; n
Keywords: Asthma Control Test; Asthma; Short-acting beta-agonist; Bronchodilator agents; Asthma exacerbation; Asthma rescue medication; ACT; Asthma Control Test; AUC; Area under the curve; ICS; Inhaled corticosteroid; MDI; Metered-dose inhaler; NPV; Negative predic
Keywords: ICS; Inhaled corticosteroids; LABA; Long acting beta-agonist; SABA; Short-acting beta-agonist; GC; gluco-corticosteroids; SDB; Sleep disordered breathing;
Keywords: Biologic therapy; Comorbidities; Adherence; Inhaled corticosteroid; Phenotype; Severe asthma; ABPA; Allergic bronchopulmonary aspergillosis; AERD; Aspirin-exacerbated respiratory disease; COPD; Chronic obstructive pulmonary disease; CRS; Chronic rhinosinu
Keywords: Asthma; Asthma exacerbation; Viral infection; Allergy; Prevention; Treatment; Inhaled corticosteroids; Long-acting β2-agonists; Leukotriene antagonist; Anticholinergics; Anti-IgE; Anti-IL5; Systemic corticosteroids; ED; Emergency department; FEV1; Forced
Keywords: Asthma; Control; Biologics; Eosinophilic asthma; Severe asthma; Uncontrolled asthma; DDP-4; dipeptidyl peptidase 4; Feno; fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; inhaled corticosteroid; LABA; long-acting beta2 agonist; S
Keywords: Childhood asthma; Phenotype; Refractory asthma; Severe asthma; Gene expression; Corticosteroid; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; ICS; inhaled corticosteroid; PBMC; peripheral blood mononuclear cell; SABA; shor
Keywords: Administrative data; Corticosteroid; Comorbidities; Allergist; Asthma specialist; Asthma control; Blood eosinophil count; Chronic oral corticosteroid use; Controller medication; Exacerbations; Asthma guidelines; Managed care; Persistent asthma; Short-acti
Keywords: Asthma; Adult-onset; Asthma duration; Childhood-onset; Elderly; Inflammatory biomarker; ACQ; Asthma control questionnaire; AQLQ; Asthma quality of life questionnaire; ATS; American Thoracic Society; BMI; Body mass index; BTS; British Thoracic Society; CAP
Keywords: Asthma; Telemedicine; SABA monitoring; Propeller Health; ACT; Asthma Control Test; MMG; Mercy Medical Group; NAEPP; National Asthma Education and Prevention Program; RC; Routine care; SABA; Short-acting β-agonist; WHC; Woodland Healthcare;
Keywords: Asthma; Inhaled corticosteroids; Treatment episodes; Adherence; Claims data; CMA; continuous multiple-interval measures of medication availability; EGB; Echantillon généraliste de bénéficiaires (permanent sample of beneficiaries, a 1/97th random sampl
Keywords: Asthma; discrimination; preschool child; questionnaire design; randomized controlled trial; reliability and validity; ADYC; Asthma Flare-up Diary for Young Children; MD; Mean difference; SABA; Short-acting β2-agonists; URTI; Upper respiratory tract infec
Keywords: Antiasthma agents; Asthma control; Asthma cost; Asthma impairment; Asthma risk; Asthma guidelines; Controller medication; Persistent asthma; Severe asthma; CI; Confidence interval; ED; Emergency department; GERD; Gastroesophageal reflux disease; ICD-9; Th
Keywords: Drug; Epidemiology; Inhaled corticosteroids; Inhaled β2-agonists; Inhaled muscarinic antagonists; Stroke; LAMA; inhaled long-acting anti-muscarinic antagonists; SAMA; short-acting anti-muscarinic antagonists; COPD; chronic obstructive pulmonary disease;
Keywords: asthma; eosinophil; phase 3; reslizumab; ACQ; Asthma Control Questionnaire; ADA; anti-drug antibody; AE; adverse event; FAS; full analysis set; ICS; inhaled corticosteroid; LABA; long-acting β-agonist; LS; least squares; SABA; short-acting β-agonist;
Keywords: Adrenergic beta-2 receptor agonists; Albuterol; Bronchoconstriction; Dry powder inhalers; Exercise-induced bronchospasm; AE; adverse event; ATS; American Thoracic Society; ECG; electrocardiogram; EIB; exercise-induced bronchoconstriction; FAS; full analys
Keywords: Asthma; Resource use; Outcomes; Comparative effectiveness; Propensity score; Treatment; ANCOVA; analysis of covariance; B/F; budesonide + formoterol; CI; confidence interval; F/S; fluticasone + salmeterol; ICD; international classification of diseases
Keywords: Asthma; overweight; obesity; children; dyspnea; breathlessness; shortness of breath; esophageal reflux; ACQ6; 6-Item Asthma Control Questionnaire without the FEV1 component; ACT; Asthma Control Test; ASUI; Asthma Symptom Utility Index; BMI; Body mass inde
Keywords: Asthma; asthma control; budesonide/formoterol maintenance and reliever therapy; exacerbations; Global Initiative for Asthma; predictors; risk score; ACQ-5; 5-Item Asthma Control Questionnaire; ADAS; Asthma Disease Activity Score; BMI; Body mass index; BUD
Keywords: Asthma; health care; insurance claim review; pregnancy; ED; Emergency department; ICD-10; International Classification of Diseases, 10th revision; ICS; Inhaled corticosteroid; ICU; Intensive care unit; LABA; Long-acting β2-agonist; NHI; National Health I
Keywords: Asthma; Childhood; Small-particle beclomethasone; Fluticasone; Inhaled corticosteroid; Long-acting β2-agonist; Step-up therapy; adjOR; adjusted odds ratio; adjRR; adjusted rate ratio; GP; general practice; ICS; inhaled corticosteroid; LABA; long-acting Î
Keywords: BabA; blood group antigen binding adhesin; B3GNT5; β1,3-N-acetylglucosaminyltransferase 5; B3GALT5; β1,3-galactosyltransferase 5; FUT3; fucosyltransferase 3; H. pylori; Helicobacter pylori; LabA; LacdiNAc-specific adhesin; Sialyl-Lea/x; sialyl-Lewis a/x
Keywords: Asthma; Asthma control; Maintenance of asthma control; Asthma Control Test; Asthma follow-up; Asthma exacerbations; ACT; Asthma Control Test; BMI; Body mass index; CI; Confidence interval; ED; Emergency department; SABA; Short-acting β-agonist;
Keywords: Asthma; Ageing; Clinical epidemiology; Respiratory measurement; Exhaled airway markers; FeNO; fraction of exhaled nitric oxide; SABA; short-acting beta-2-agonist; SPT; skin prick test; AHR; airway hyperresponsiveness; PRF; patient record form;
Keywords: Lung sound analysis; Airway inflammation; Bronchial asthma; Ach; Acetylcholine; E-I LF; Expiratory-inspiratory ratio of sound power in the low-frequency range; Exp LF; Sound power during expiration; FeNO; Exhaled nitric oxide; FVC; Forced vital capacity;
Keywords: asthma; Severe asthma; Asthma control; Asthma management; Prescription data; ACE; Angiotensin-converting-enzyme; COPD; Chronic obstructive pulmonary disease; ED; Emergency department; GP; General practitioner; ICS; Inhaled corticosteroid; ICS-LABA; Fixed-
Keywords: Pediatrics; Asthma; Physician training; Inhaled corticosteroids; Spirometry; %FEV1; Percentage predicted FEV1; BMI; Body mass index; CT; Computed tomography; CXR; Chest radiography; ED; Emergency department; FVC; Forced vital capacity; GERD; Gastroesophag
Keywords: BabA; blood-group antigen binding adhesion A; CagA; cytotoxin-associated antigen A; cagPAI; cag pathogenicity island; CD74; HLA II-associated invariant chain; CLR; C-type lectin receptor; IL; interleukin; FUT4; fucosyltransferase 4; HLA II; human leukocyt
Keywords: Exercise-induced bronchoconstriction; Asthma; Screening; Diagnosis; Questionnaire: Accuracy; Validity; AHR; Airway hyperresponsiveness; ATS; American Thoracic Society; EIB; Exercise-induced bronchoconstriction; EVH; Eucapnic voluntary hyperventilation; FE
Keywords: Asthma; Comparative effectiveness; Retrospective cohort study; Inhaled corticosteroids; Long-acting β2-adrenergic agonist; short-acting β2-adrenergic-agonists; Budesonide-formoterol combination; Fluticasone-salmeterol combination; BFC; Budesonide-form
Keywords: Asthma; Treatment; Inhaled corticosteroids; Daily; Intermittent; API; asthma predictive index; CI; confidence interval; FEV1; forced volume in the first second; HR; hazard ratio; ICS; inhaled corticosteroids; MD; mean difference; PEF; peak expiratory flow
Keywords: Asthma; Sex differences; Symptom profiles; Control; ACQ; Asthma Control Questionnaire; ALA-ACRC; American Lung Association Asthma Clinical Research Centers; ASUI; Asthma Symptom Utility Index; ATAQ; Asthma Therapy Assessment Questionnaire; BMI; body mass
Keywords: Montelukast; smoking; fluticasone propionate; leukotriene receptor antagonist; asthma control; corticosteroids; AE; Adverse experience; COPD; Chronic obstructive pulmonary disease; FVC; Forced vital capacity; PEF; Peak expiratory flow; SABA; Short-acting
Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA
Keywords: Combination therapy; COPD; Inhaled corticosteroids; Long-acting bronchodilators; LAMA/LABA; Fixed-dose dual bronchodilators; CDS; Chronic Disease Score; CI; confidence interval; COPD; chronic obstructive pulmonary disease; ER; emergency room; FDC; fixed-d
Improving the performance of virtual crossmatch results by correlating with nationally-performed physical crossmatches: Obtaining additional value from proficiency testing activities
Keywords: DSA; Donor Specific Antibody/Donor Specific Allo-antibody; CAP; College of American Pathologists; AMR; antibody-mediated rejection; XM; Cross Match; FC; Flow Cytometry; SABA; Single Antigen Bead Assay; UA; Unacceptable Antigen; SD; Standard Deviation; MFI
The Journal of Allergy and Clinical Immunology: In Practice 2017 Year in Review
Keywords: Angioedema; Allergy; Asthma; Anaphylaxis; Atopic dermatitis; Contact dermatitis; Drug allergy; Eosinophilic esophagitis; Eosinophilia; Food allergy; Immunodeficiency; Immunotherapy; Rhinitis; Rhinosinusitis; Urticaria; AAAAI; American Academy of Allergy A
Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids
Keywords: Asthma; Child; Inhaled corticosteroid; Long-acting β-agonist; Step-up therapy; aOR; Adjusted odds ratio; aRR; Adjusted rate ratio; BDP; Beclomethasone dipropionate; BTS/SIGN; The British Thoracic Society and Scottish Intercollegiate Guidelines Network; C
Optimal treatment sequence in COPD: Can a consensus be found?
Keywords: COPD; Treatment sequence; SABA; SAMA; LABA; LAMA; ICS; Triple therapy; Non-inhaled therapies